Evidence map›Paper›PMID 34830863›Full record

ArticleCancers2021

Tumor Suppressive Circular RNA-102450: Development of a Novel Diagnostic Procedure for Lymph Node Metastasis from Oral Cancer.

Toshiaki Ando, Atsushi Kasamatsu, Kohei Kawasaki, Kazuya Hiroshima, Reo Fukushima, Manabu Iyoda, Dai Nakashima, Yosuke Endo-Sakamoto, Katsuhiro Uzawa

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Toshiaki AndoDepartment of Oral Science, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Atsushi KasamatsuDepartment of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba 260-8677, Japan.
Kohei KawasakiDepartment of Oral Science, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Kazuya HiroshimaDepartment of Oral Science, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Reo FukushimaDepartment of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba 260-8677, Japan.
Manabu IyodaDepartment of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba 260-8677, Japan.
Dai NakashimaDepartment of Oral Science, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Yosuke Endo-SakamotoDepartment of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba 260-8677, Japan.
Katsuhiro UzawaDepartment of Oral Science, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.ORCID 0000-0002-7036-0859
Chiba University · JPChiba University Hospital · JP

Funding

Ministry of Education, Culture, Sports, Science and Technology 19H03847
6 · The paper itself

Abstract

Circular RNAs (circRNAs), which form as covalently closed loop structures, have several biological functions such as regulation of cellular behavior by adsorbing microRNAs. However, there is limited information of circRNAs in oral squamous cell carcinoma (OSCC). Here, we aimed to elucidate the roles of aberrantly expressed circRNAs in OSCC. CircRNA microarray showed that circRNA-102450 was down-regulated in OSCC cells. Clinical validation of circRNA-102450 was performed using highly sensitive droplet digital PCR in preoperative liquid biopsy samples from 30 OSCC patients. Interestingly, none of 16 studied patients with high circRNA-102450 had regional lymph node metastasis (RLNM), whereas 4 of 14 studied patients (28.5%) with low expression had pathologically proven RLNM. Overexpressed circRNA-102450 significantly inhibited the tumor metastatic properties of cell proliferation, migration, and invasion. Furthermore, circRNA-102450 directly bound to, and consequently down-regulated, miR-1178 in OSCC cells. Taken together, circRNA-102450 has a tumor suppressive effect via the circRNA-102450/miR-1178 axis and may be a novel potential marker of RLNM in OSCC patients.

Indexed as

circRNAdroplet digital PCRliquid biopsymiRNAregional lymph node metastasis

Identifiers

PMID34830863
PMCPMC8616294
OpenAlexW3211794971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.